Related Articles
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
Radium‑223 in patients with metastatic castration‑resistant prostate cancer: Efficacy and safety in clinical practice
Paclitaxel and carboplatin chemotherapy after platinum‑based chemotherapy and pembrolizumab for metastatic urothelial carcinoma
Clinical use of molecular targeted agents for primary small bowel adenocarcinoma: A multicenter retrospective cohort study by the Osaka Gut Forum
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: A phase II trial